Synthetic Diagnostics

PathCrisp

Overview

PathCrisp is a next-gen diagnostics platform combining CRISPR-based detection, microfluidic hardware, and cloud-based bioinformatics. Focused on identifying multi-pathogen threats and antimicrobial resistance, this project is built for high-impact deployment in both clinical and field settings.

Precision CRISPR detection

01

Uses CRISPR-Cas systems for ultra-specific and sensitive detection of microbial and viral signatures.

Precision CRISPR detection

01

Uses CRISPR-Cas systems for ultra-specific and sensitive detection of microbial and viral signatures.

Precision CRISPR detection

01

Uses CRISPR-Cas systems for ultra-specific and sensitive detection of microbial and viral signatures.

Real-Time resistance mapping

02

Targets antimicrobial resistance profiles, enabling clinicians to respond with precision therapies.

Real-Time resistance mapping

02

Targets antimicrobial resistance profiles, enabling clinicians to respond with precision therapies.

Real-Time resistance mapping

02

Targets antimicrobial resistance profiles, enabling clinicians to respond with precision therapies.

Portable & Scalable

03

Microfluidic design allows for rapid, low-cost deployment in labs, clinics, or mobile health units.

Portable & Scalable

03

Microfluidic design allows for rapid, low-cost deployment in labs, clinics, or mobile health units.

Portable & Scalable

03

Microfluidic design allows for rapid, low-cost deployment in labs, clinics, or mobile health units.

Modular bioscience, at your fingertips

Modular bioscience, at your fingertips

Modular bioscience, at your fingertips

Come build the future of decentralized science with us.

Address

501 Massachusetts Ave, Cambridge, MA 02139

Boston

16:45:16

©2025 BioVergence All Rights Reserved

Come build the future of decentralized science with us.

Address

501 Massachusetts Ave, Cambridge, MA 02139

Boston

16:45:16

©2025 BioVergence All Rights Reserved

Synthetic Diagnostics

PathCrisp

Overview

PathCrisp is a next-gen diagnostics platform combining CRISPR-based detection, microfluidic hardware, and cloud-based bioinformatics. Focused on identifying multi-pathogen threats and antimicrobial resistance, this project is built for high-impact deployment in both clinical and field settings.

Precision CRISPR detection

01

Uses CRISPR-Cas systems for ultra-specific and sensitive detection of microbial and viral signatures.

Precision CRISPR detection

01

Uses CRISPR-Cas systems for ultra-specific and sensitive detection of microbial and viral signatures.

Precision CRISPR detection

01

Uses CRISPR-Cas systems for ultra-specific and sensitive detection of microbial and viral signatures.

Real-Time resistance mapping

02

Targets antimicrobial resistance profiles, enabling clinicians to respond with precision therapies.

Real-Time resistance mapping

02

Targets antimicrobial resistance profiles, enabling clinicians to respond with precision therapies.

Real-Time resistance mapping

02

Targets antimicrobial resistance profiles, enabling clinicians to respond with precision therapies.

Portable & Scalable

03

Microfluidic design allows for rapid, low-cost deployment in labs, clinics, or mobile health units.

Portable & Scalable

03

Microfluidic design allows for rapid, low-cost deployment in labs, clinics, or mobile health units.

Portable & Scalable

03

Microfluidic design allows for rapid, low-cost deployment in labs, clinics, or mobile health units.

Modular bioscience, at your fingertips

Modular bioscience, at your fingertips

Modular bioscience, at your fingertips

Come build the future of decentralized science with us.

Address

50 Milk Street, 15th Floor
Boston, MA 02109

Contact

hello@biovergence.co

Boston

16:45:16

©2025 BioVergence All Rights Reserved